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Abstract
Introduction: Adenoid cystic carcinoma (ACC) of the larynx is a rare malignancy characterized by an indolent course 
and late pulmonary metastases. Metastases from the larynx to the spleen are an unusual event. In the present report, 
we discuss a patient with adenoid cystic carcinoma of the larynx metastatic to the spleen. A review of the literature did 
not yield any other such incidents. We review the clinical presentation and course of adenoid cystic carcinoma, as well 
as the role of splenectomy for metastases.
Case presentation: We present a case of laryngeal adenoid cystic carcinoma in a 26-year-old Caucasian man treated 
with total laryngectomy and ionizing radiation. He initially developed asynchronous pulmonary metastases, which 
were resected. Our patient subsequently presented with a symptomatic splenic lesion consistent with metastatic 
disease, for which he underwent laparoscopic splenectomy.
Conclusions: Splenectomy might be indicated for isolated metastases. A splenectomy effectively addresses symptoms 
and serves as a cytoreduction modality.
Introduction
Adenoid cystic carcinoma (ACC) is a rare, malignant
tumor, which usually originates from the minor salivary
glands. The laryngeal variant, arising from the glandular
components of the larynx, is extremely atypical [1]. A
review of the literature on ACC demonstrates only 15
cases reported in the past 40 years in a compressive anal-
ysis of the topic [2]. Another review interrogated 1342
cases of laryngeal tumors and identified five cases of ACC
[3]. The management for both the laryngeal and glandu-
lar components consists of surgical resection and ioniz-
ing radiation, which is aimed to achieve local control.
However, these modalities do not seem to affect mortal-
ity, which is typically the result of metastatic disease [2,4].
Prophylactic lymph node dissection is only indicated for
clinically involved nodes [5,6]. ACC is characterized by
an indolent growth pattern and late distant metastasis,
most commonly to the lungs [2]. Owing to the slow
growth and indolent nature of this malignancy, survival
for patients with laryngeal ACC is measured in decades
[2,5]. Thus, in contrast to other malignancies, ACC sur-
vival is typically not measured as five-year mortality, but
more commonly at 10 or 20 years [7]. Pulmonary metas-
tasectomies have been reported for isolated lesions from
ACC [8]. Glandular ACC has a predilection for the lungs,
but has also been reported to metastasize to other organs
including brain, bone, liver, thyroid and spleen [9]. The
natural history of salivary gland ACC indicates that aver-
age time between diagnosis of the primary tumor and
death was 60.1 months and the interval between occur-
rence of metastases and death was 33.0 months [9].
In the present discussion, we address the need to per-
form a splenectomy in an unusual clinical situation of a
metastatic lesion from ACC. We present a review of the
literature on metastatic lesions to the spleen and the role
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A 26-year-old Caucasian man was referred to the surgical
service with an enlarging splenic mass and left upper
quadrant pain. The pain was described as dull with no
exacerbating factors. He had no nausea or vomiting and
no other systemic complaints. He had a history of laryn-
geal ACC that was treated with total laryngectomy and
adjuvant radiation three years prior to this clinical visit.
Within a year of the original diagnosis and treatment of
ACC, our patient developed a single right lung metastasis
for which he underwent thoracotomy with resection.
This was followed by recurrence in the ipsilateral lung,
which was again resected. He was started on Tarceva
(erlotinib), an EGFR inhibitor used to treat non-small cell
lung cancer, but the therapy was discontinued secondary
to an intolerable rash.
During follow up a computed tomography (CT) scan of
the chest demonstrated bilateral lung nodules, which
were consistent with metastatic disease (Figure 1B).
However, there were no symptoms attributable to these
lesions. The CT scan also demonstrated a lesion in the
spleen that measured 4cm and was approximately 1mm
from the splenic capsule (Figure 1A). He was referred to
the surgical service when a follow up CT scan of the
abdomen three months later demonstrated progression
in size of the lesion by 1cm and our patient complained of
left upper quadrant abdominal discomfort. There was no
evidence of other intra-abdominal disease. Due to the
progression in size of the splenic lesion, its proximity to
the capsule with potential complications of rupture or
local advancement, and in light of our patient's symptoms
the decision was made to proceed with laparoscopic sple-
nectomy. He was given appropriate pre-operative immu-
nization. At the time of surgery, there was no evidence of
other intra-abdominal disease. The spleen (Figure 2A)
was removed intact through an enlarged port site inci-
sion. Pathologic examination (Figure 2B) showed a 5.2 ×
4.3 × 4cm single metastatic nodule within 0.1cm from the
capsule. The mass shows mucoid areas in the center and
microscopically had features characteristic of adenoid
cystic carcinoma with a predominant cribriform growth
pattern. He had a routine convalescence, and is currently
alive and well.
Discussion
Involvement of the spleen as a result of metastatic disease
is an unusual event, which occurs in 0.96% to 7.1% of
patients with carcinoma as demonstrated by autopsy
examinations [10,11]. Splenic metastases often herald late
stage disease and are typically associated with multi-vis-
ceral metastatic disease. The organ of origin is most com-
monly breast, followed by lung, colorectal, ovary,
stomach and skin (Figure 3) [12]. Isolated splenic metas-
tasis is an even more atypical condition. A recent review
of the literature reported only 93 cases of solitary splenic
metastasis [13]. The majority of metastases were of col-
orectal and ovarian origin (Figure 4) [13]. The increased
incidence of ovarian splenic metastases may be related to
the route of spread (peritoneal seeding versus blood
borne metastases) and the close radiographic and clinical
follow-up that these patients undergo.
Splenectomy for metastases has been previously
reported (Table 1). The most common indication for
splenectomy is as part of cytoreductive therapy in
patients with ovarian cancer as this might increase the
therapeutic efficacy of systemic chemotherapy [14-16]. A
splenectomy for the management of colon cancer and
melanoma has also been successfully performed as a dis-
Figure 3 Chart showing the source of splenic metastases from a 
large autopsy review[12].
Figure 2 Gross pathologic specimen (A), and microscopic view 
demonstrating characteristic cribriform pattern abutting splenic 
capsule (B).
A B
Figure 1 Computed tomography revealed splenic lesion (A, iden-
tified with arrow) and demonstrating metastatic lung lesions (B, 
identified with arrows).
A B
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nancies [17,18]. The cases presented in Table 1 indicate
the potential therapeutic benefit of splenectomy as the
average post-operative survival for these patients is from
11.1 to 29.3 months.
The present report is unique in its presentation of
laryngeal ACC metastatic to the spleen. This case also
illustrates the need to proceed with splenectomy for the
management of symptoms and also to prevent substantial
adverse outcomes that might result from further tumor
involvement. Because of the indolent nature of ACC, a
splenic lesion might achieve substantial growth, which if
left untreated might rupture causing lethal hemorrhage
or erode into the adjacent structures (i.e. diaphragm)
causing significant symptoms and morbidity.
Conclusions
Splenic metastasis is a rare event. When it occurs, splenic
metastasis is usually associated with widespread meta-
static disease. Splenectomy may be considered for
patients with isolated disease, patients needing cytore-
duction prior to adjuvant therapy, and for those patients
with symptomatic disease.
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Figure 4 Chart demonstrating source of solitary splenic metasta-
sis[13].
Table 1: Splenectomy for metastatic disease.
Reference de wilt [17] Lee [15] Nicklin [16] Gemignani [14] Sileri [18] Agha-Mohammadi [19]
Number 15 31 18 6 16 54
Age 52.7 (37-84) 61 (39-79) 58.1 (30-78) 59 (58-60) 65 (33-81) n/a
M:f 6.5:1 01:09.3 0:18 0:06 1.8:1 n/a
Primary tumor
Gynecologic 0 23 14 6 0 33
Colorectal 0 2 0 0 16 8
Melanoma 15 0 0 0 0 1
Lung 0 1 0 0 0 5
Peritoneum 1 3 0 0 0
Other 0 4 1 0 0 7
Solitary lesion 6/15 n/a n/a n/a 16/16 n/a
Survival in months 
(range)
11.3 (1-31) 22.9 (1-72) 11 dead @ 12 (5-59.5) NED @ 28 (6-65) not reported 31 NED @ 29.1 (6-144)
5 alive with disease 5 with disease @ 20.2 (6-72)
2 NED 6 dead
12 unknown
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